[Combination therapy for chronic viral hepatitis C]

Dtsch Med Wochenschr. 2003 Feb 21;128(8):370-4. doi: 10.1055/s-2003-37369.
[Article in German]
No abstract available

Publication types

  • Review

MeSH terms

  • Amantadine / therapeutic use
  • Antiviral Agents / adverse effects
  • Antiviral Agents / therapeutic use*
  • Drug Therapy, Combination
  • Hepatitis C, Chronic / drug therapy*
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / adverse effects
  • Interferon-alpha / therapeutic use
  • Polyethylene Glycols / adverse effects
  • Polyethylene Glycols / therapeutic use
  • Recombinant Proteins
  • Ribavirin / adverse effects
  • Ribavirin / therapeutic use
  • Treatment Outcome

Substances

  • Antiviral Agents
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Polyethylene Glycols
  • Ribavirin
  • Amantadine
  • peginterferon alfa-2b
  • peginterferon alfa-2a